skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Opposition

Number:91283950Filing Date:03/15/2023
Status:TerminatedStatus Date:07/12/2023
General Contact Number:571-272-8500
Interlocutory Attorney:LAWRENCE (LARRY) T STANLEY
Paralegal Name:ROCHELLE L ADAMS
Defendant
Name:Axcentria Pharmaceuticals, LLC
Correspondence:MARY L. SHAPIRO
EVOKE LAW, PC
201 SPEAR STREET, SUITE 1100, #16
SAN FRANCISCO, CA 94105
UNITED STATES
iplaw@evoke.law, mary@evoke.law, nicole@evoke.law
Phone: 415-398-3141
 
Serial #:90880618Application FileAssignment
Application Status: ABANDONED - AFTER INTER-PARTES DECISION
Mark: ELEA
Plaintiff
Name:Regeneron Pharmaceuticals, Inc.
Correspondence:PAUL C. LLEWELLYN
ARNOLD & PORTER KAYE SCHOLER LLP
250 WEST 55TH STREET
NEW YORK, NY 10019
UNITED STATES
trademarkdocketing@arnoldporter.com, paul.llewellyn@arnoldporter.com, hannah.grace@arnoldporter.com, amit.kesar@arnoldporter.com
Phone: 212-836-7828
 
Serial #:77510978Application FileAssignmentRegistration #:4088223
Application Status: REGISTERED AND RENEWED
Mark: EYLEA
 
Serial #:85209921Application FileAssignmentRegistration #:4100104
Application Status: REGISTERED AND RENEWED
Mark: EYLEA
 
Serial #:85955455Application FileAssignmentRegistration #:4566649
Application Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Mark: EYLEA (AFLIBERCEPT) INJECTION 4U
 
Serial #:85327081Application FileAssignmentRegistration #:4191718
Application Status: REGISTERED AND RENEWED
Mark: EYLEA4U
 
Serial #:87722615Application FileAssignmentRegistration #:5524177
Application Status: REGISTERED
Mark: EYLEA
 
Serial #:90701063Application FileAssignment
Application Status: FOURTH EXTENSION - GRANTED
Mark: EYLEA
Prosecution History
#DateHistory TextDue Date
907/12/2023TERMINATED
807/12/2023BD DECISION: OPP DISMISSED W/O PREJ
707/12/2023W/DRAW OF APPLICATION W/ CONSENT
606/20/2023SUSPENDED
506/20/2023P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
403/23/2023ANSWER
303/15/2023INSTITUTED
203/15/2023NOTICE AND TRIAL DATES SENT; ANSWER DUE:04/24/2023
103/15/2023FILED AND FEE
Results as of 04/24/2024 01:07 PM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY